Abivax S.A.
ABVX | NASDAQ
$103.56
-$1.48 (-1.41%)
Sep 21, 2026, 11:26 AM ET · Market open
Fiscal Quarter Period Ending | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | 2.33M | 2.25M | 2.25M | 2.23M | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 378K | 329K | 32K | 39K | 124K | 32K | 33K | 33K |
Gross Profit | n/a | n/a | n/a | n/a | 2.33M | 2.25M | 2.25M | 2.23M | -124K | -32K | -33K | -33K |
Operating Income | -199.56M | -46.5M | -47.2M | -35.33M | -92.46M | -39.54M | -38.8M | -18.63M | -25.69M | -26.53M | -23.38M | -16.21M |
Interest Income | 807K | 319K | 1.09M | 2.45M | n/a | n/a | 113K | 15K | 84K | n/a | n/a | n/a |
Pretax Income | -281.84M | -48.41M | -52.37M | -38.77M | -98.05M | -54.19M | -42.55M | -31.77M | -27.42M | -18.14M | -24.7M | -15.42M |
Net Income | -287.69M | -48.41M | -52.37M | -38.77M | -95.79M | -51.95M | -40.29M | -29.55M | -24.83M | -16.53M | -22.13M | -15.42M |
Selling & General & Admin | 27.69M | 8.94M | 8.89M | 12.05M | 21.53M | 6.58M | 5.27M | 2.22M | 2.3M | 2.45M | 2.28M | 2.7M |
Research & Development | 44.4M | 38.65M | 39.3M | 28.91M | 70.55M | 32.62M | 32.84M | 15.11M | 23.25M | 23.96M | 21.06M | 13.47M |
Other Expenses | 127.47M | -1.09M | -994K | -5.63M | 1 | -7K | -1K | 10.93M | 17K | 96K | 15K | -9K |
Operating Expenses | 199.56M | 46.5M | 47.2M | 35.33M | 92.08M | 39.21M | 37.99M | 28.26M | 25.56M | 26.5M | 23.35M | 16.18M |
Interest Expense | 15.27M | 3.52M | 4.54M | 3.83M | 5.7M | 14.7M | 1.81M | 2.13M | 2.18M | 1.03M | 1.36M | 963K |
Selling & Marketing Expenses | 14K | 34K | 172K | 352K | 5.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 199.56M | 46.5M | 47.2M | 35.33M | 92.46M | 39.54M | 38.02M | 18.63M | 25.69M | 26.53M | 23.38M | 16.21M |
Income Tax Expense | 5.85M | n/a | n/a | n/a | -2.26M | -2.24M | -2.26M | -2.22M | -2.59M | -1.61M | -2.58M | n/a |
Shares Outstanding (Basic) | 69.53M | 63.41M | 63.17M | 62.92M | 48.29M | 35.9M | 22.3M | 16.77M | 16.76M | 14.66M | 14.31M | 12.21M |
Shares Outstanding (Diluted) | 69.53M | 63.41M | 63.17M | 62.92M | 48.29M | 35.9M | 22.3M | 16.77M | 16.76M | 14.66M | 14.31M | 12.21M |
EPS (Basic) | -2.10 | -1.59 | -1.50 | -0.65 | -1.98 | -1.45 | -1.81 | -1.76 | -1.48 | -1.13 | -1.55 | -1.26 |
EPS (Diluted) | -2.10 | -1.59 | -1.50 | -0.65 | -1.98 | -1.45 | -1.81 | -1.76 | -1.48 | -1.13 | -1.55 | -1.26 |
EBITDA | -256.06M | -44.64M | -47.56M | -34.58M | -92.08M | -39.21M | -36.15M | -15.02M | -25.12M | -26.5M | -23.35M | -16.18M |
EBIT | -256.88M | -44.89M | -47.84M | -34.94M | -92.35M | -39.49M | -36.19M | -15.05M | -25.24M | -26.52M | -23.35M | -16.21M |
Depreciation & Amortization | 821K | 251K | 273K | 365K | 378K | 329K | 32K | 39K | 124K | 32K | 33K | 33K |
Add to Watchlist
Select watchlists to add or remove ABVX